CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1 Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis Exercise Therapy and Cardiovascular Toxicity in Cancer Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2 Lack of Association Between Heart Failure and Incident Cancer

Review Article2018 Mar 13;137(11):1176-1191.

JOURNAL:Circulation Article Link

Exercise Therapy and Cardiovascular Toxicity in Cancer

Scott JM, Nilsen TS, Gupta D et al. Keywords: cardiorespiratory fitness; cardiotoxicity; exercise; heart failure; survivorship

ABSTRACT


Cardio-oncology is an emerging discipline focused predominantly on the detection and management of cancer treatment-induced cardiac dysfunction (cardiotoxicity), which predisposes to development of overt heart failure or coronary artery disease. The direct adverse consequences, as well as those secondary to anticancer therapeutics, extend beyond the heart, however, to affect the entire cardiovascular-skeletal muscle axis (ie, whole-organism cardiovascular toxicity). The global nature of impairment creates a strong rationale for treatment strategies that augment or preserve global cardiovascular reserve capacity. In noncancer clinical populations, exercise training is an established therapy to improve cardiovascular reserve capacity, leading to concomitant reductions in cardiovascular morbidity and its attendant symptoms. Here, we overview the tolerability and efficacy of exercise on cardiovascular toxicity in adult patients with cancer. We also propose a conceptual research framework to facilitate personalized risk assessment and the development of targeted exercise prescriptions to optimally prevent or manage cardiovascular toxicity after a cancer diagnosis.